Dow Jones

38,798.99

-0.22%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Prothena Corp. Plc - Ordinary Shares (MM) (PRTAV)
Prothena Corp. Plc - Ordinary Shares (MM) (PRTAV) Noticias

PRTAV

Prothena Corp. Plc - Ordinary Shares (MM) (PRTAV)

Prothena Corp. Plc - Ordinary Shares (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PRTAV

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
27/10/2022	15:05	GlobeNewswire Inc.	Prothena to Report Third Quarter 2022 Financial Results on November 3rd	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
01/09/2022	15:20	GlobeNewswire Inc.	Prothena to Participate in Upcoming Healthcare Conferences	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
01/09/2022	15:05	GlobeNewswire Inc.	Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
08/08/2022	15:05	GlobeNewswire Inc.	Prothena Reports Second Quarter 2022 Financial Results and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
02/08/2022	15:05	GlobeNewswire Inc.	Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
01/08/2022	15:05	GlobeNewswire Inc.	Prothena to Report Second Quarter 2022 Financial Results on August 8th	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
02/06/2022	15:05	GlobeNewswire Inc.	Prothena to Participate in Jefferies Healthcare Conference	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
05/05/2022	15:05	GlobeNewswire Inc.	Prothena Reports First Quarter 2022 Financial Results and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
28/04/2022	15:05	GlobeNewswire Inc.	Prothena to Report First Quarter 2022 Financial Results on May 5th	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
26/04/2022	07:30	GlobeNewswire Inc.	Prothena Receives FDA Fast Track Designation for PRX012, a Next-Generation Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
28/03/2022	07:30	GlobeNewswire Inc.	Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
21/03/2022	15:05	GlobeNewswire Inc.	Prothena to Participate in Stifel 2022 Virtual CNS Days	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
16/03/2022	04:30	GlobeNewswire Inc.	Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
17/02/2022	15:05	GlobeNewswire Inc.	Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
10/02/2022	15:05	GlobeNewswire Inc.	Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
29/11/2021	15:05	GlobeNewswire Inc.	Prothena to Participate in JMP Securities Hematology and Oncology Summit	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
04/11/2021	15:05	GlobeNewswire Inc.	Prothena Reports Third Quarter 2021 Financial Results and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
28/10/2021	15:05	GlobeNewswire Inc.	Prothena to Report Third Quarter 2021 Financial Results on November 4th	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
01/10/2021	15:05	GlobeNewswire Inc.	Prothena Announces Executive Appointments	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
03/09/2021	15:05	GlobeNewswire Inc.	Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
01/09/2021	15:05	GlobeNewswire Inc.	Prothena to Participate in Upcoming September Healthcare Conferences	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
05/08/2021	15:05	GlobeNewswire Inc.	Prothena Reports Second Quarter 2021 Financial Results and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
29/07/2021	15:05	GlobeNewswire Inc.	Prothena to Report Second Quarter 2021 Financial Results on August 5th	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
26/07/2021	08:00	GlobeNewswire Inc.	Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association International Conference 2021	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
20/07/2021	15:05	GlobeNewswire Inc.	Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association International Confer...	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
12/07/2021	06:00	GlobeNewswire Inc.	Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
24/06/2021	07:30	GlobeNewswire Inc.	Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global Neuroscience Research and ...	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
10/06/2021	13:18	GlobeNewswire Inc.	Prothena to Participate in JMP Securities Life Sciences Conference on June 16	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
20/05/2021	15:05	GlobeNewswire Inc.	Prothena Announces Appointment of Sanjiv Patel, MBBS, to its Board of Directors	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
11/05/2021	15:05	GlobeNewswire Inc.	Prothena Reports First Quarter 2021 Financial Results and Provides Updated Financial Guidance and R&D Update	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)